Total Payments
$9,895
2024 Payments
$2,683
Companies
21
Transactions
107
Medicare Patients
3,186
Medicare Billing
$194,336
Payment Breakdown by Category
Food & Beverage$6,560 (66.3%)
Travel$3,335 (33.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,560 | 96 | 66.3% |
| Travel and Lodging | $3,335 | 11 | 33.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Noah Medical Corporation | $2,871 | 9 | $0 (2024) |
| Covidien LP | $2,444 | 12 | $0 (2020) |
| Pulmonx Corporation | $1,590 | 11 | $0 (2023) |
| Ethicon Inc. | $1,530 | 22 | $0 (2024) |
| Boston Scientific Corporation | $307.79 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $196.91 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $162.61 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $139.65 | 2 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $111.55 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $81.04 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,683 | 18 | Noah Medical Corporation ($2,264) |
| 2023 | $3,050 | 39 | Pulmonx Corporation ($1,424) |
| 2022 | $853.06 | 20 | Ethicon Inc. ($388.27) |
| 2021 | $541.16 | 11 | Ethicon Inc. ($510.90) |
| 2020 | $2,485 | 14 | Covidien LP ($2,444) |
| 2019 | $227.09 | 2 | Janssen Pharmaceuticals, Inc ($125.00) |
| 2017 | $54.95 | 3 | GlaxoSmithKline, LLC. ($20.77) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $86.61 | General |
| Category: Endo-Mechanical | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $20.35 | General |
| Category: Medical Device | ||||||
| 07/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: RESPIRATORY | ||||||
| 06/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/08/2024 | Noah Medical Corporation | GALAXY (Device) | Travel and Lodging | Cash or cash equivalent | $176.88 | General |
| Category: Bronchoscope (Flexible Or Rigid) And Accessories | ||||||
| 04/08/2024 | Noah Medical Corporation | GALAXY (Device) | Travel and Lodging | Cash or cash equivalent | $68.92 | General |
| Category: Bronchoscope (Flexible Or Rigid) And Accessories | ||||||
| 04/08/2024 | Noah Medical Corporation | GALAXY (Device) | Travel and Lodging | Cash or cash equivalent | $52.00 | General |
| Category: Bronchoscope (Flexible Or Rigid) And Accessories | ||||||
| 03/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $34.65 | General |
| 03/14/2024 | Noah Medical Corporation | GALAXY (Device) | Food and Beverage | Cash or cash equivalent | $1,965.81 | General |
| Category: Bronchoscope (Flexible Or Rigid) And Accessories | ||||||
| 03/14/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $17.80 | General |
| Category: Medical Device | ||||||
| 02/29/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $90.48 | General |
| Category: General - Pulmonary_ENDO | ||||||
| 02/08/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $16.00 | General |
| Category: Medical Device | ||||||
| 01/15/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: Oncology | ||||||
| 01/09/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Respiratory | ||||||
| 12/14/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: RESPIRATORY | ||||||
| 12/07/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $17.88 | General |
| Category: Medical Device | ||||||
| 11/22/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Respiratory | ||||||
| 11/15/2023 | Noah Medical Corporation | — | Food and Beverage | Cash or cash equivalent | $163.91 | General |
| Category: Pulmonary Disease | ||||||
| 10/26/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $20.59 | General |
| Category: SLEEP MEDICINE | ||||||
| 09/25/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,016 | 1,107 | $205,398 | $49,147 |
| 2022 | 18 | 1,143 | 1,346 | $263,332 | $71,005 |
| 2021 | 17 | 825 | 1,017 | $160,507 | $59,901 |
| 2020 | 11 | 202 | 234 | $35,394 | $14,283 |
Total Patients
3,186
Total Services
3,704
Medicare Billing
$194,336
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 95 | $19,950 | $8,217 | 41.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 58 | 104 | $17,160 | $6,438 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 99 | $14,751 | $6,351 | 43.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 45 | 45 | $19,800 | $6,108 | 30.8% |
| 31653 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | Facility | 2023 | 19 | 19 | $38,570 | $3,246 | 8.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 22 | $5,500 | $2,997 | 54.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $5,670 | $2,627 | 46.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $4,840 | $2,623 | 54.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 21 | $4,935 | $1,956 | 39.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $5,436 | $1,832 | 33.7% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 160 | 161 | $4,818 | $1,303 | 27.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 186 | 187 | $2,860 | $1,135 | 39.7% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 12 | 12 | $27,000 | $885.46 | 3.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 100 | 101 | $8,594 | $733.06 | 8.5% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 12 | 12 | $828.00 | $661.44 | 79.9% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 109 | 113 | $8,693 | $605.07 | 7.0% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 23 | 24 | $13,488 | $493.21 | 3.7% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 19 | 19 | $1,425 | $469.98 | 33.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 12 | $1,080 | $466.56 | 43.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 169 | $24,280 | $15,434 | 63.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 86 | 87 | $38,280 | $13,578 | 35.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 88 | 199 | $32,835 | $11,092 | 33.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 41 | $7,910 | $5,257 | 66.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 16 | 27 | $10,665 | $4,683 | 43.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 27 | 27 | $7,290 | $4,232 | 58.0% |
About Mihir Buch
Mihir Buch is a Pulmonary Disease healthcare provider based in Erie, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2014. The National Provider Identifier (NPI) number assigned to this provider is 1124446026.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mihir Buch has received a total of $9,895 in payments from pharmaceutical and medical device companies, with $2,683 received in 2024. These payments were reported across 107 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($6,560).
As a Medicare-enrolled provider, Buch has provided services to 3,186 Medicare beneficiaries, totaling 3,704 services with total Medicare billing of $194,336. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Erie, PA
- Active Since 03/29/2014
- Last Updated 05/24/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1124446026
Products in Payments
- superDimension (Device) $2,444
- GALAXY (Device) $2,264
- Monarch Platform (Device) $1,530
- ZEPHYR ENDOBRONCHIAL VALVE (Device) $1,112
- CHARTIS CATHETER (Device) $311.71
- DUPIXENT (Biological) $187.70
- ZEPHYR DELIVERY CATHETER (Device) $166.15
- XARELTO (Drug) $139.65
- EXALT Model D (Device) $124.40
- TRELEGY ELLIPTA (Drug) $102.09
- OFEV (Drug) $81.13
- NUCALA (Biological) $74.05
- Arikayce (Drug) $71.42
- (AK6) Vest Therapy (Device) $54.15
- FASENRA (Biological) $49.53
- (8874) inCourage (Device) $48.52
- WAKIX (Drug) $48.11
- STIOLTO RESPIMAT (Drug) $46.83
- RYBREVANT (Drug) $28.07
- REMICADE (Biological) $24.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Erie
Dr. Stephen Kovacs, D.o, D.O
Pulmonary Disease — Payments: $463,374
Pulmonary Disease $463,374
Gary Esper, D.o, D.O
Pulmonary Disease — Payments: $12,884
Pulmonary Disease $12,884
Mario Kinsella
Pulmonary Disease — Payments: $1,798
Pulmonary Disease $1,798
Dr. Animesh Gour, Md, MD
Pulmonary Disease — Payments: $1,427
Pulmonary Disease $1,427
Anisha Kamath, M.b.b.s, M.B.B.S
Pulmonary Disease — Payments: $852.52
Pulmonary Disease $852.52
Kyle Long, M.d, M.D
Pulmonary Disease — Payments: $542.63
Pulmonary Disease $542.63